Background-Evidence is sparse about the genetic determinants of major lipids in Pakistanis. Methods and Results-Variants (nϭ45 000) across 2000 genes were assessed in 3200 Pakistanis and compared with 2450 Germans using the same gene array and similar lipid assays. We also did a meta-analysis of selected lipid-related variants in Europeans. Pakistani genetic architecture was distinct from that of several ethnic groups represented in international reference samples. Forty-one variants at 14 loci were significantly associated with levels of HDL-C,
triglyceride, or LDL-C. The most significant lipid-related variants identified among Pakistanis corresponded to genes previously shown to be relevant to Europeans, such as CETP associated with HDL-C levels (rs711752; PϽ10 Ϫ13 ), APOA5/ZNF259 (rs651821; PϽ10 Ϫ13 ) and GCKR (rs1260326; PϽ10 Ϫ13 ) with triglyceride levels; and CELSR2 variants with LDL-C levels (rs646776; PϽ10 Ϫ9 ). For Pakistanis, these 41 variants explained 6.2%, 7.1%, and 0.9% of the variation in HDL-C, triglyceride, and LDL-C, respectively. Compared with Europeans, the allele frequency of rs662799 in APOA5 among Pakistanis was higher and its impact on triglyceride concentration was greater (P-value for difference Ͻ10 Ϫ4 ). Conclusions-Several lipid-related genetic variants are common to Pakistanis and Europeans, though they explain only a modest proportion of population variation in lipid concentration. Allelic frequencies and effect sizes of lipid-related variants can differ between Pakistanis and Europeans. (Circ Cardiovasc Genet. 2010;3:348-357.)
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IBC-array Ⅲ meta-analysis L evels of major blood lipids-that is, concentrations of low-and high-density lipoprotein cholesterol (LDL-C and HDL-C) and triglyceride-are each strongly, log-linearly, and positively (or, in the case of HDL-C, inversely) associated with the risk of coronary heart disease (CHD). 1, 2 Linkage and twin based studies suggest that more than 50% of the variation in these circulating lipids is determined by genetic factors. [3] [4] [5] Several genetic variants have been established in the regulation of lipid metabolism in people of European continental ancestry, including 40 genomic loci (represented by 152 SNPs) identified in genome-wide association studies. [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] In contrast with considerable evidence available on people of European ancestry, data on genetic regulation of major blood lipids in Pakistanis are limited. For example, the previous largest relevant study reported on 5 genetic markers in relation to a few hundred participants. 17 
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We report the first large-scale study of the genetic determinants of LDL-C, HDL-C and triglyceride concentrations in people living in Pakistan, a country of Ͼ180 million people with a high burden of cardiovascular disease. We have assayed over 45 000 single nucleotide polymorphisms (SNPs) across 2000 candidate genes using the ITMAT-Broad-CARe (IBC) array 18 in 3200 participants from the Pakistan Risk of Myocardial Infarction Study (PROMIS). 19 We compared association signals observed in PROMIS with those in 2450 participants of German ancestry from the Ludwigshafen Risk and Cardiovascular Health (LURIC) prospective study, which used the same gene array. 20 To place the German findings in the context of data from other populations of European ancestry, we did a meta-analysis of published studies.
Materials and Methods

Participants
This report follows the reporting recommendations of STREGA. 21 PROMIS is a case-control study of acute myocardial infarction (MI) in 6 centers in urban Pakistan. 20 MI cases had symptoms within 24 hours of hospital presentation, typical ECG changes, and a positive troponin-I test. Control subjects were individuals without a history of cardiovascular disease. They were frequency-matched to cases by sex and age (in 5-year bands) and concurrently identified in the same hospitals as index cases because they were either (1) visitors of patients attending the outpatient department, (2) patients attending the outpatient department for routine noncardiac complaints, or (3) non-blood-related visitors of index MI cases. People with recent illnesses or infections were not eligible. Information was recorded on personal and parental ethnicity, spoken language, dietary intake, lifestyle factors, and other characteristics. Nonfasting blood samples (with the time since last meal recorded) were drawn from each participant and centrifuged within 45 minutes of venepuncture. Serum samples were stored at Ϫ80°C. Total cholesterol, HDL-C, and triglyceride concentrations were measured using enzymatic methods (Roche Diagnostics, USA) at the Center for Non-Communicable Diseases, Pakistan. LDL-C concentration was calculated using the Friedewald formula. 22 LURIC is a prospective study of cardiovascular death in individuals of German ancestry resident in southwest Germany who underwent elective coronary angiography and left ventriculography between June 1997 and January 2000. 21 CHD in the current analyses was defined by troponin-confirmed MI (ie, acute ST-or non-ST elevation MI or based on past medical records) or presence of visible luminal narrowing of Ն50% in at least 1 coronary vessel. Individuals with Ն20% but Ͻ50% stenosis were excluded from the analyses. Individuals with stenosis Ͻ20% were regarded as control subjects. Fasting blood samples collected before angiography were kept frozen at Ϫ80°C between the day of blood draw and the day of analysis for total cholesterol, HDL-C and triglycerides (all determined enzymatically).
The studies were approved by relevant ethics committees, and participants gave informed consent.
Genotyping
All genotyping was performed at the Wellcome Trust Sanger Institute using the "IBC" array of about 2000 candidate genes. 18 Variants on the array were selected on the basis of (1) genes with known associations for various cardiovascular, pulmonary, and sleep related disorders, (2) information from pathway-based tools for the identification of biologically plausible candidate genes, (3) unpublished functional experiments in mice, (4) findings from various genome-wide scans, and (5) priority SNPs identified by IBC consortium investigators. 18 SNPs (nϭ45 237) in version 1 of this array were genotyped in the PROMIS participants and were called using the Illuminus algorithm. 23 Markers were excluded from analysis if the call rate was Ͻ95% (372 SNPs); there was evidence of departure from Hardy-Weinberg Equilibrium at a probability value of Ͻ10 Ϫ3 (1750 SNPs); or the minor allele frequency (MAF) was Ͻ1% (11 931 SNPs, with most such omissions due to genetic markers relevant in Africans being uninformative in Pakistanis and Europeans). LURIC participants were typed with version 2 of the IBC array and underwent the same calling and quality control procedures. Because version 2 has 4050 additional SNPs, these SNPs were excluded from the current analysis. After quality control, 31 883 SNPs in 3197 Pakistanis and 35 533 SNPs in 2452 Germans were available for analyses.
Statistical Methods
To compare the genetic structure of Pakistanis with that of several major ethnic groups, we received permission from HapMap3 inves-tigators to conduct principal components analyses on 1124 participants in HapMap3. We selected 19 931 SNPs in common with the PROMIS sample, and excluded 11 952 A/T and C/G SNPs to avoid possible strand alignment bias because it is difficult to infer the minor allele for A/T or C/G SNPs for non-HapMap populations. 8 To investigate genetic substructure, we classified Pakistani participants into 8 self-identified ethnic and linguistic groups and calculated principal components on the matrix of identity-by-state sharing of all pairs of individuals. Quantile-quantile plots were produced by plotting the observed Ϫlog 10 probability value for each lipid against the expected Ϫlog 10 probability value. The association between each lipid measure and genetic variants was tested using linear regression.
Additive models calculated the change in lipid level per copy of the minor allele. 〉-coefficients have been reported using the common allele as the reference allele in PROMIS. All analyses were done using models adjusting for age and sex, the first 2 principal components and case-control status. Effect estimates in LURIC were reported for the same allele taken as reference in PROMIS.
The Bonferroni correction for the 32 000 SNPs for 3 traits is 10 Ϫ7 , assuming 96 000 independent tests with no prior information. We chose a cutoff 10 Ϫ6 owing to the likely higher prior odds of association because the array involves candidate genes and because there is a high degree of correlation between the tested SNPs. To reduce potential biases, lipid analyses were stratified by case-control status and excluded participants on lipid-lowering medication at the time of baseline examination. Analyses used PLINK 1.06, R version 2.9.1, and STATA 10.0.
Meta-Analysis
We sought genetic association studies of lipid-related variants in people of European ancestry published between January 1970 and January 2009. We focused on SNPs (ie, rs1800775, rs708272, rs646776, and rs662799) identified as top signals in the Pakistan study to enable comparison of their impact in Europeans (with the exception of rs780093, for which there was minimal previous data, owing to its completely recent discovery). Electronic searches involved MEDLINE, EMBASE, BIOSIS, and Science Citation index and combined search terms related to genes (eg, cholesteryl ester transfer protein [CETP]) and lipids (eg, HDL-C) without language restriction. These searches were supplemented by scanning reference lists, hand-searching relevant journals, and correspondence with authors. Two investigators independently extracted the following information: mean and SD of lipid levels by genotype; proportion of males; fasting status; and assay methods. Analyses involved only within-study comparisons. Mean levels of lipids (and differences in mean levels in comparison with the common homozygotes) were calculated using both fixed and random-effects models (as the latter makes allowances for between-study heterogeneity). Probability values for difference between the effect estimates obtained in PROMIS and European participants were calculated through a 2 test of heterogeneity.
Results
The main characteristics of the Pakistani and German participants in this study are summarized in the Table. Comparison with HapMap3 population panels shows that the Pakistani population clustered distinctly from 11 other major ethnic groups, indicated by the separate clustering on the scatterplot of principal components (Figure 1 ). Pakistanis appear genetically closest to, but still clearly distinct from, Gujarati Indians living in the United States, a group that is known to differ genetically from Indians living in India. 24 Analysis of the 8 ethnic and linguistic groups in the Pakistani study suggested the possibility of relatively minor population substructure; the different ethnicities could not be demarcated discretely on the scatter plots involving different principal components ( Figure 1 and the online-only Data Supplement Figure 1 ). Compared with Germans, the Pakistani participants were about a decade younger and had broadly similar LDL-C and triglyceride values but lower HDL-C (Table) .
Variants With Highly Significant Associations
Under an additive model, linear regression analysis for each lipid measure identified several SNPs deviating from the expected 2 values as shown by the quantile-quantile plots in Figure 2 . A total of 25 variants in 4 genomic regions were associated with lipid levels in Pakistanis (PՅ10 Ϫ6 ), including 16 variants for HDL-C, 8 variants for triglycerides, and 1 variant for LDL-C. All 16 HDL-C-related variants were on the cholesteryl ester transfer protein (CETP) gene (10 Ϫ14 ϽPϽ10 Ϫ6 ; Figure 3A and online-only Data Supplement Table 1 ). Each copy of the minor allele of rs711752, the lead SNP, was associated with 0.048 mmol/L (95% CI, 0.04 to 0.06; PϽ10 Ϫ14 ) higher HDL-C levels. MAFs and effect sizes of the CETP variants in Pakistanis were broadly similar to those observed in this German population ( Figure 3A) , with overlapping genetic association signals and a similar pattern of linkage disequilibrium (LD) in this region (Figure 4 ). Subsidiary analyses in PROMIS cases and control participants for these variants revealed qualitatively similar results (online-only Data Supplement Figures 2a to 2c) .
To further explore LD patterns in Europeans, subsidiary analyses were conducted in CEU HapMap2 data, which revealed a similar pattern of LD in the CEU HapMap2 population and LURIC participants (data available on request). As shown in contrast, the association of the C-629A variant with HDL-C appeared somewhat stronger in Europeans than in Pakistanis ( 2 test for difference, Pϭ2ϫ10 Ϫ4 ; Figure 5 and online-only Data Supplement Figure 3a-1b ). Eight variants in 2 genomic regions were highly significantly associated with log triglyceride concentration in the Pakistani participants. The most significant SNP (rs662799; Pϭ1.25ϫ 10 Ϫ14 ) localized to the APOA5 gene ( Figure 3B and online-only Data Supplement Table 1 ). Each copy of the rs662799-C allele at this locus was associated with a 0.14 mmol/L higher log triglyceride concentration ( Figures 3B and 4) , with MAF about 2 times higher in the Pakistani than German participants (0.17 versus 0.07). This variant was in strong LD with several other variants in APOA5 and nearby ZNF259 that were also significantly associated with triglyceride concentration but apparently not in LD with any of the variants in APOA1, APOC3 or APOA4. Overall, APOA5 variants appeared to have stronger LD and associations with triglyceride concentration in Pakistani than in German participants (Figure 4) . Meta-analysis of rs662799 in available European studies yielded 0.20 mmol/L (0.14 to 0.26) higher triglyceride per each copy of the minor allele (18 studies, 20 963 participants: Figure 5 and online-only Data Supplement Figure 3D ), an effect size that was lower than that observed in the Pakistani participants ( 2 for difference, Pϭ7ϫ10 Ϫ4 ; Figure  5 ). Three variants in the glucokinase regulatory protein (GCKR) gene highly significantly associated with triglyceride in Pakistanis (PϽ10 Ϫ6 ) had broadly similar-sized effects in Germans ( Figure 3B ).
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Only rs646776 in the cadherin, EGF LAG 7-pass G-type receptor 2 (CELSR2) gene was highly significantly associated with LDL-C concentration in the Pakistani participants (Pϭ1.25ϫ10 Ϫ10 ) and was associated with a 0.16 mmol/L (Ϫ0.23 to Ϫ0.08) lower LDL-C concentration per copy of the minor allele. This variant was not significantly associated with LDL-C concentration in the German participants (nϭ1175), perhaps owing to limited statistical power. Analyses conducted earlier in a larger LURIC study population (nϭ3189) for the same locus yielded a similar association with LDL-C levels to that observed in Pakistanis. 25 The current meta-analysis of rs646776, however, established this variant's relevance more reliably in Europeans, yielding an overall 0.15 mmol/L (Ϫ0.17 to Ϫ0.14) lower LDL-C per each copy of the minor allele (14 studies, 48 445 participants; Figure 5 ), an effect size comparable to that observed in Pakistanis ( 2 test for difference, Pϭ0.84; Figure 5 and online-only Data Supplement Figure 3c ).
No significant interactions were observed on an additive scale of the 25 top variants with lipid measures by ghee or tobacco consumption or by sex (online-only Data Supplement Figure 4 ). Qualitatively similar results were observed in analyses adjusted for time since onset of MI symptoms in 875 cases in PROMIS with relevant information (available on request).
Variants With Nominally Significant Associations
Of the 152 lipid-related SNPs discovered through previous genome-wide association studies in European populations, 49 were covered by the gene array used in the current study (23 for HDL-C, 17 for LDL-C, and 17 for triglycerides with a few SNPs associated with 2 or all 3 traits). At a prespecified nominal value of PϽ0.01, 12 of the 23 established HDL-Crelated variants were associated with HDL-C concentration (including 7 variants described earlier in CETP and 5 other variants in LIPG, LIPC, and DPEP2); 10 of the established 17 triglyceride-related variants were associated with triglyceride concentration (including 3 variants described earlier in APOA5 and GCKR and 7 other variants in DOCK7, TBL2, LPL, BAZ1b, and APOB); and 5 of the 17 established LDL-C-related variants were associated with LDL-C concen- tration (including 1 variant in CELSR2 described above and 4 other variants in FADS1, FADS2 and CELSR2: online-only Data Supplement Figure 5 ). Hence, we identified a total of 41 different variants significantly related to major lipid levels in Pakistanis (ie, 25 variants at PϽ10 Ϫ6 and a further 16 variants at PϽ10 Ϫ2 ). Analyses of these genes in PROMIS and LURIC participants revealed a similar pattern of LD, with somewhat stronger LD blocks in APOB and LPL genes in Pakistanis than in Europeans (online-only Data Supplement Figure 6 ). Collectively, in the Pakistani participants, these variants explained 6.2%, 7.1%, and 0.9% of the variation in HDL-C, triglyceride, and LDL-C, respectively, whereas corresponding analyses in the German participants explained 5.9%, 7.2%, and 0.71% of the variation in these lipids, respectively.
Subsidiary analyses yielded odds ratio for MI in Pakistanis with each of the 41 principal SNPs that were compatible with the direction of associations of each of these variants with lipid concentration, although the current study was underpowered for reliable gene-MI analyses (online-only Data Supplement Figure 7 ).
Discussion
The current study has identified a total of 41 variants at 14 loci that were significantly associated with levels of HDL-C, triglyceride or LDL-C in Pakistanis. The most highly significant lipid-related variants identified among Pakistanis corresponded to genes previously shown to be relevant to lipid metabolism in Europeans, such as CETP, APOA5, and CELSR2. Even collectively, however, the top variants explained only 6.2%, 7.1%, and 0.9% of the population variation in HDL-C, triglyceride, and LDL-C levels in Pakistanis, respectively (a similar proportion of lipid variation was explained by the top signals in our parallel analysis of Germans). The current study has also suggested some differences in allelic frequencies and magnitude of association with lipids for variants in APOA5 in Pakistanis compared with Europeans. As discussed below, however, further studies are needed to confirm whether such differences are mainly related to ethnicity rather than other characteristics.
Most of the highly significant lipid-related loci identified in Pakistani participants were related to HDL-C and triglyceride rather than LDL-C concentration, a finding that is consistent with a lower yield of genetic loci associated with LDL-C in previous GWA studies in Europeans. [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] For HDL-C, our most highly significant findings related to the CETP gene. 26 HDL is believed to exert atheroprotective effects through several mechanisms, including transfer of cholesterol from peripheral tissues to liver. 26, 27 CETP facilitates this process by exchanging cholesterol esters from HDL with triglyceride in apolipoprotein B-containing particles. 26 Deficiency of this protein leads to higher HDL-C levels and other lipoprotein abnormalities. 25, 26 Our meta-analysis focused on the Taq1B and C-629A variants in CETP, which alter CETP mass and activity and, consequently, increase HDL-C concentration. 27 For triglyceride, our most highly significant findings related to variants in APOA5, which is part of the APOA1/C3/A4/A5 gene cluster localized to chromosome 11q23. 28, 29 It has been proposed that APOAV regulates lipoprotein lipase-mediated hydrolysis of triglycerides contained in VLDL particles. 28 Further triglyceride-related variants were found in GCKR, 30 which regulates activity of glucokinase, a key enzyme responsible for the first rate-limiting step in the glycolysis pathway, deficiency of which alters glucose and lipoprotein metabolism. 31 For LDL-C, the sole highly significant finding related to a variant in CELSR2, 32 a gene that expresses itself along with PSRC1 and SORT1 within a transcriptional network proposed to regulate metabolic profile and atherosclerosis, 32, 33 although precise mechanisms remain unknown.
Compared with the German participants we studied, the frequency of the rs662799-C allele in the APOA5 locus was higher in Pakistanis and appeared to have a greater impact on triglyceride concentration. However, as at least part of these differences could have been due to nonethnic factors (eg, differences in sample size and/or population sampling frameworks used), further study is needed. Evidence of ethnic-related differences is emerging from other contexts, such as suggestions that total cholesterol is a stronger risk factor among South Asians than Europeans 34 and that the LTA4H haplotype has higher odds ratios for myocardial infarction in Africans than Europeans. 35 The value of large ethnic-specific studies has also been illustrated by the discovery of the strongest common susceptibility locus (KCNQ1) yet for T2D, 36 -38 identified in East Asians but not initially in Europeans because the allele frequency in East Asians is much higher (40% versus 5%) despite similar odds ratios in both populations. 36 -38 For reasons of feasibility, we used existing genetic tools based on catalogues of genetic variation mostly discovered in Europeans, East Asians, and West Africans, even though we were aware that these tools may not adequately capture genetic variation in Pakistanis (or other South Asians). 39, 40 For example, the recent discovery of a 7-fold relative risk for heart failure with the 25-bp deletion allele in the MYBPC3 gene would have remained undetected using conventional platforms because this variant is present only in South Asians. 41 Further study in Pakistanis is therefore needed involving better populationspecific tools for genetic mapping. Larger replication studies should also help to quantify and control any overestimation in hypothesis-generating estimates. Such studies should aim to involve fine-mapping of relevant loci (eg, APOA5) and functional studies. 42 Future studies may also yield stronger (or novel) genetic signals by direct assay of LDL-C rather than, as in the current study, calculation of LDL-C using the Friedewald formula. However, as a large prospective study has shown that associations of major lipids with CHD risk are at least as extreme in nonfasted participants as in fasted participants, 41 use of nonfasting samples in the current study seems unlikely to have influenced materially the findings here.
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